In COPD patients, elevated ET‐1 levels in sputum, plasma, and urine may disrupt the regulation of ocular microvessels, leading to abnormal blood flow distribution and changes in RNFL thickness [38, 39]. Here, EDN1 is linked to chronic obstructive pulmonary disease.